Aromatase in bone: Roles of Vitamin D3 and androgens

Toshihiko Yanase, Shizu Suzuki, Kiminobu Goto, Masatoshi Nomura, Taijiro Okabe, Ryoichi Takayanagi, Hajime Nawata

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

We have mainly focused on the regulatory mechanism of cytochrome P450 aromatize in bone cells. Our previous study demonstrated a strong positive correlation of serum dehydroepiandrosterone sulfate (DHEA-S) and estrone (E1) with BMD in postmenopausal women but no correlation between serum estradiol (E2) and BMD in the same group. In addition, administration of DHEA to ovariectomized rat significantly increased BMD. These in vivo findings strongly suggested that circulating adrenal androgen may be converted to estrogen in osteoblast and may contribute to BMD maintenance. Actually, in cultured human osteoblast cells, DHEA was found to convert to androstenedione by 3β-hydroxysteroid dehydrogenase (3β-HSD) activity and then androstenedione to estrone through the apparent aromatase activity. The aromatase activity in cultured human osteoblast cells was significantly increased by dexamethasone (DEX). Interestingly, DEX and 1α,25- dihydroxyvitamin D3 (VD3) synergistically enhanced aromatase activity as well as P450arom mRNA expression. A little stronger induction of aromatase activity by DEX and VD3 was observed in cultured human fibroblasts. The increase of the aromatase activity by DEX and VD3 was accompanied with the increase of luciferase activity of fibroblast cells transfected with Exon 1b-promoter-luciferase construct, but not of osteoblasts transfected with the same construct, suggesting a different regulatory mechanism of aromatase by DEX and 1α,25-dihydroxyvitamin D 3 (VD3) between these two cells despite the same promotor usuage. In human bone cells, intracrine mechanism through aromatase activity, together with a positive regulation of aromatase activity by glucocorticoid and VD3, may contribute to the local production of estrogens, thus leading to protective effect against osteoporosis especially after menopause. The effect of sex steroids (estrogen versus testosterone) in bone remodeling was also briefly reviewed based on several recent findings in this field.

Original languageEnglish
Pages (from-to)393-397
Number of pages5
JournalJournal of Steroid Biochemistry and Molecular Biology
Volume86
Issue number3-5
DOIs
Publication statusPublished - Sep 2003

Fingerprint

Aromatase
Cholecalciferol
Androgens
Bone
Bone and Bones
Dexamethasone
Osteoblasts
Estrogens
Dehydroepiandrosterone
Androstenedione
Estrone
Fibroblasts
Luciferases
3-Hydroxysteroid Dehydrogenases
Dehydroepiandrosterone Sulfate
Calcitriol
Bone Remodeling
Menopause
Serum
Cytochrome P-450 Enzyme System

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Endocrinology
  • Clinical Biochemistry
  • Cell Biology

Cite this

Yanase, T., Suzuki, S., Goto, K., Nomura, M., Okabe, T., Takayanagi, R., & Nawata, H. (2003). Aromatase in bone: Roles of Vitamin D3 and androgens. Journal of Steroid Biochemistry and Molecular Biology, 86(3-5), 393-397. https://doi.org/10.1016/S0960-0760(03)00349-2

Aromatase in bone : Roles of Vitamin D3 and androgens. / Yanase, Toshihiko; Suzuki, Shizu; Goto, Kiminobu; Nomura, Masatoshi; Okabe, Taijiro; Takayanagi, Ryoichi; Nawata, Hajime.

In: Journal of Steroid Biochemistry and Molecular Biology, Vol. 86, No. 3-5, 09.2003, p. 393-397.

Research output: Contribution to journalArticle

Yanase, T, Suzuki, S, Goto, K, Nomura, M, Okabe, T, Takayanagi, R & Nawata, H 2003, 'Aromatase in bone: Roles of Vitamin D3 and androgens', Journal of Steroid Biochemistry and Molecular Biology, vol. 86, no. 3-5, pp. 393-397. https://doi.org/10.1016/S0960-0760(03)00349-2
Yanase, Toshihiko ; Suzuki, Shizu ; Goto, Kiminobu ; Nomura, Masatoshi ; Okabe, Taijiro ; Takayanagi, Ryoichi ; Nawata, Hajime. / Aromatase in bone : Roles of Vitamin D3 and androgens. In: Journal of Steroid Biochemistry and Molecular Biology. 2003 ; Vol. 86, No. 3-5. pp. 393-397.
@article{0a31256484f3437cb1cf29a246300cfc,
title = "Aromatase in bone: Roles of Vitamin D3 and androgens",
abstract = "We have mainly focused on the regulatory mechanism of cytochrome P450 aromatize in bone cells. Our previous study demonstrated a strong positive correlation of serum dehydroepiandrosterone sulfate (DHEA-S) and estrone (E1) with BMD in postmenopausal women but no correlation between serum estradiol (E2) and BMD in the same group. In addition, administration of DHEA to ovariectomized rat significantly increased BMD. These in vivo findings strongly suggested that circulating adrenal androgen may be converted to estrogen in osteoblast and may contribute to BMD maintenance. Actually, in cultured human osteoblast cells, DHEA was found to convert to androstenedione by 3β-hydroxysteroid dehydrogenase (3β-HSD) activity and then androstenedione to estrone through the apparent aromatase activity. The aromatase activity in cultured human osteoblast cells was significantly increased by dexamethasone (DEX). Interestingly, DEX and 1α,25- dihydroxyvitamin D3 (VD3) synergistically enhanced aromatase activity as well as P450arom mRNA expression. A little stronger induction of aromatase activity by DEX and VD3 was observed in cultured human fibroblasts. The increase of the aromatase activity by DEX and VD3 was accompanied with the increase of luciferase activity of fibroblast cells transfected with Exon 1b-promoter-luciferase construct, but not of osteoblasts transfected with the same construct, suggesting a different regulatory mechanism of aromatase by DEX and 1α,25-dihydroxyvitamin D 3 (VD3) between these two cells despite the same promotor usuage. In human bone cells, intracrine mechanism through aromatase activity, together with a positive regulation of aromatase activity by glucocorticoid and VD3, may contribute to the local production of estrogens, thus leading to protective effect against osteoporosis especially after menopause. The effect of sex steroids (estrogen versus testosterone) in bone remodeling was also briefly reviewed based on several recent findings in this field.",
author = "Toshihiko Yanase and Shizu Suzuki and Kiminobu Goto and Masatoshi Nomura and Taijiro Okabe and Ryoichi Takayanagi and Hajime Nawata",
year = "2003",
month = "9",
doi = "10.1016/S0960-0760(03)00349-2",
language = "English",
volume = "86",
pages = "393--397",
journal = "Journal of Steroid Biochemistry and Molecular Biology",
issn = "0960-0760",
publisher = "Elsevier Limited",
number = "3-5",

}

TY - JOUR

T1 - Aromatase in bone

T2 - Roles of Vitamin D3 and androgens

AU - Yanase, Toshihiko

AU - Suzuki, Shizu

AU - Goto, Kiminobu

AU - Nomura, Masatoshi

AU - Okabe, Taijiro

AU - Takayanagi, Ryoichi

AU - Nawata, Hajime

PY - 2003/9

Y1 - 2003/9

N2 - We have mainly focused on the regulatory mechanism of cytochrome P450 aromatize in bone cells. Our previous study demonstrated a strong positive correlation of serum dehydroepiandrosterone sulfate (DHEA-S) and estrone (E1) with BMD in postmenopausal women but no correlation between serum estradiol (E2) and BMD in the same group. In addition, administration of DHEA to ovariectomized rat significantly increased BMD. These in vivo findings strongly suggested that circulating adrenal androgen may be converted to estrogen in osteoblast and may contribute to BMD maintenance. Actually, in cultured human osteoblast cells, DHEA was found to convert to androstenedione by 3β-hydroxysteroid dehydrogenase (3β-HSD) activity and then androstenedione to estrone through the apparent aromatase activity. The aromatase activity in cultured human osteoblast cells was significantly increased by dexamethasone (DEX). Interestingly, DEX and 1α,25- dihydroxyvitamin D3 (VD3) synergistically enhanced aromatase activity as well as P450arom mRNA expression. A little stronger induction of aromatase activity by DEX and VD3 was observed in cultured human fibroblasts. The increase of the aromatase activity by DEX and VD3 was accompanied with the increase of luciferase activity of fibroblast cells transfected with Exon 1b-promoter-luciferase construct, but not of osteoblasts transfected with the same construct, suggesting a different regulatory mechanism of aromatase by DEX and 1α,25-dihydroxyvitamin D 3 (VD3) between these two cells despite the same promotor usuage. In human bone cells, intracrine mechanism through aromatase activity, together with a positive regulation of aromatase activity by glucocorticoid and VD3, may contribute to the local production of estrogens, thus leading to protective effect against osteoporosis especially after menopause. The effect of sex steroids (estrogen versus testosterone) in bone remodeling was also briefly reviewed based on several recent findings in this field.

AB - We have mainly focused on the regulatory mechanism of cytochrome P450 aromatize in bone cells. Our previous study demonstrated a strong positive correlation of serum dehydroepiandrosterone sulfate (DHEA-S) and estrone (E1) with BMD in postmenopausal women but no correlation between serum estradiol (E2) and BMD in the same group. In addition, administration of DHEA to ovariectomized rat significantly increased BMD. These in vivo findings strongly suggested that circulating adrenal androgen may be converted to estrogen in osteoblast and may contribute to BMD maintenance. Actually, in cultured human osteoblast cells, DHEA was found to convert to androstenedione by 3β-hydroxysteroid dehydrogenase (3β-HSD) activity and then androstenedione to estrone through the apparent aromatase activity. The aromatase activity in cultured human osteoblast cells was significantly increased by dexamethasone (DEX). Interestingly, DEX and 1α,25- dihydroxyvitamin D3 (VD3) synergistically enhanced aromatase activity as well as P450arom mRNA expression. A little stronger induction of aromatase activity by DEX and VD3 was observed in cultured human fibroblasts. The increase of the aromatase activity by DEX and VD3 was accompanied with the increase of luciferase activity of fibroblast cells transfected with Exon 1b-promoter-luciferase construct, but not of osteoblasts transfected with the same construct, suggesting a different regulatory mechanism of aromatase by DEX and 1α,25-dihydroxyvitamin D 3 (VD3) between these two cells despite the same promotor usuage. In human bone cells, intracrine mechanism through aromatase activity, together with a positive regulation of aromatase activity by glucocorticoid and VD3, may contribute to the local production of estrogens, thus leading to protective effect against osteoporosis especially after menopause. The effect of sex steroids (estrogen versus testosterone) in bone remodeling was also briefly reviewed based on several recent findings in this field.

UR - http://www.scopus.com/inward/record.url?scp=0242626130&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242626130&partnerID=8YFLogxK

U2 - 10.1016/S0960-0760(03)00349-2

DO - 10.1016/S0960-0760(03)00349-2

M3 - Article

C2 - 14623536

AN - SCOPUS:0242626130

VL - 86

SP - 393

EP - 397

JO - Journal of Steroid Biochemistry and Molecular Biology

JF - Journal of Steroid Biochemistry and Molecular Biology

SN - 0960-0760

IS - 3-5

ER -